HSA
GILD icon

HBK Sorce Advisory’s Gilead Sciences GILD Stock Holding History

HBK Sorce Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.08M Sell
31,034
-4,046
-12% -$567K 0.08% 90
2025
Q4 		$5.35M Sell
35,080
-2,828
-7% -$344K 0.12% 70
2025
Q3 		$4.48M Sell
37,908
-1,329
-3% -$151K 0.11% 79
2025
Q2 		$4.35M Buy
39,237
+109
+0.3% +$11.6K 0.12% 77
2025
Q1 		$4.38M Sell
39,128
-1,740
-4% -$180K 0.13% 76
2024
Q4 		$3.77M Sell
40,868
-94
-0.2% -$8.46K 0.11% 80
2024
Q3 		$3.43M Sell
40,962
-2,483
-6% -$189K 0.1% 91
2024
Q2 		$2.98M Buy
43,445
+6,556
+18% +$438K 0.1% 93
2024
Q1 		$2.7M Buy
36,889
+1,892
+5% +$145K 0.1% 111
2023
Q4 		$2.84M Buy
34,997
+2,898
+9% +$226K 0.11% 107
2023
Q3 		$2.41M Buy
32,099
+952
+3% +$73.2K 0.11% 112
2023
Q2 		$2.4M Sell
31,147
-2,394
-7% -$191K 0.1% 119
2023
Q1 		$2.78M Sell
33,541
-37,943
-53% -$3.14M 0.13% 106
2022
Q4 		$6.14M Buy
71,484
+35,861
+101% +$2.84M 0.17% 90
2022
Q3 		$2.2M Buy
35,623
+1,965
+6% +$124K 0.15% 109
2022
Q2 		$2.08M Sell
33,658
-991
-3% -$61.4K 0.15% 102
2022
Q1 		$2.06M Buy
34,649
+3,500
+11% +$224K 0.11% 125
2021
Q4 		$2.26M Buy
31,149
+589
+2% +$40.6K 0.11% 125
2021
Q3 		$2.13M Sell
30,560
-179
-0.6% -$12.6K 0.12% 127
2021
Q2 		$2.12M Buy
30,739
+316
+1% +$21.1K 0.12% 129
2021
Q1 		$1.97M Buy
30,423
+6,528
+27% +$421K 0.12% 129
2020
Q4 		$1.39M Buy
23,895
+5,730
+32% +$346K 0.09% 156
2020
Q3 		$1.15M Buy
18,165
+2,451
+16% +$170K 0.08% 158
2020
Q2 		$1.21M Buy
15,714
+1,309
+9% +$100K 0.09% 147
2020
Q1 		$1.08M Buy
14,405
+1,950
+16% +$135K 0.1% 129
2019
Q4 		$809K Buy
12,455
+596
+5% +$38.8K 0.07% 197
2019
Q3 		$752K Buy
11,859
+268
+2% +$17.5K 0.07% 197
2019
Q2 		$783K Sell
11,591
-1,174
-9% -$77.2K 0.08% 186
2019
Q1 		$830K Buy
12,765
+2,040
+19% +$136K 0.08% 176
2018
Q4 		$671K Buy
10,725
+1,117
+12% +$78.1K 0.08% 185
2018
Q3 		$742K Sell
9,608
-410
-4% -$31K 0.08% 164
2018
Q2 		$710K Sell
10,018
-681
-6% -$48.1K 0.08% 169
2018
Q1 		$807K Buy
10,699
+1,676
+19% +$133K 0.1% 151
2017
Q4 		$646K Sell
9,023
-207
-2% -$15.7K 0.08% 186
2017
Q3 		$748K Sell
9,230
-606
-6% -$46.3K 0.11% 126
2017
Q2 		$696K Sell
9,836
-520
-5% -$34.6K 0.11% 136
2017
Q1 		$703K Sell
10,356
-2,087
-17% -$147K 0.12% 128
2016
Q4 		$891K Sell
12,443
-3,681
-23% -$274K 0.16% 101
2016
Q3 		$1.28M Buy
16,124
+415
+3% +$33.7K 0.25% 63
2016
Q2 		$1.31M Buy
15,709
+1,150
+8% +$102K 0.28% 61
2016
Q1 		$1.34M Buy
14,559
+4,113
+39% +$371K 0.32% 50
2015
Q4 		$1.06M Buy
10,446
+238
+2% +$24.8K 0.28% 56
2015
Q3 		$1M Buy
10,208
+1,316
+15% +$146K 0.33% 44
2015
Q2 		$1.04M Sell
8,892
-150
-2% -$16.4K 0.35% 47
2015
Q1 		$887K Buy
9,042
+464
+5% +$47.1K 0.3% 55
2014
Q4 		$809K Buy
8,578
+2,615
+44% +$270K 0.28% 60
2014
Q3 		$635K Buy
5,963
+3
+0.1% +$294 0.23% 62
2014
Q2 		$494K Buy
5,960
+351
+6% +$27.3K 0.17% 84
2014
Q1 		$397K Buy
5,609
+839
+18% +$65.8K 0.14% 96
2013
Q4 		$358K Sell
4,770
-5
-0.1% -$348 0.13% 107
2013
Q3 		$300K Sell
4,775
-4,773
-50% -$285K 0.12% 118
2013
Q2 		$490K Buy
+9,548
New +$498K 0.11% 134

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HBK Sorce Advisory's GILD Position: Q1 2026 in Review

HBK Sorce Advisory reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $567K and leaving 31,034 shares worth $4.08M. The position accounts for 0.08% of the portfolio, ranked #90.

HBK Sorce Advisory first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.14M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • HBK Sorce Advisory held 31,034 shares of Gilead Sciences worth $4.08M as of Q1 2026.
  • HBK Sorce Advisory sold 4,046 Gilead Sciences shares in Q1 2026, an estimated $567K.
  • Gilead Sciences made up 0.08% of HBK Sorce Advisory's portfolio in Q1 2026, its #90 holding.
  • HBK Sorce Advisory first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • HBK Sorce Advisory's Gilead Sciences position peaked at $6.14M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.